LONDON, April 8: As preparations for the second edition of the London Biotechnology Show (LBS25) gather momentum, organisers have announced that registration for the event will be free, a move intended to support greater participation from across the global biotechnology community.
The event, which returns for its second year, has drawn interest from a wide range of stakeholders, including policy-makers, researchers, innovators, investors and other life sciences professionals.
#LBS25 is set to feature a comprehensive lineup of speakers, exploring key trends and developments in biotechnology. Topics such as gene editing, regenerative medicine, pharmaceuticals, bioinformatics, medical devices, biomedical engineering, and the latest in digital health. are expected to take centre stage during the two-day conference.
Confirmed speakers represent a cross-section of major players in the field, including experts from Microsoft, Roche, Pfizer, Bayer Pharmaceuticals, Genomics England, and the Medicines and Healthcare products Regulatory Agency. Click to Check the Entire List of Speakers.
In parallel, the exhibition floor will showcase over 100 companies offering solutions across biotech R&D, diagnostics, pharma services, laboratory innovation, etc. Among the confirmed exhibitors are Discovery Park, Thistle Scientific, Haier Biomedical UK Ltd, Merck, and a lot more. Link to the entire list of exhibitors.
A Hosted Buyer Programme will run alongside the show, designed to facilitate targeted meetings between exhibitors and decision-makers, encouraging strategic business connections and partnerships.
With registration now open and free to all attendees, LBS25 offers an opportunity for a wider audience to engage with some of the most current conversations shaping biotechnology today.
For media enquiries and partnership requests: Contact Dr. Muhammad Younis, PR & Communications Lead – London Biotechnology Show- muhammad.younis@valiantbmedia.com
